Fortrea Holdings FTRE
NASDAQ FTRE
$16.68 -0.11 (-0.66%)
As of: Sep 10, 2026 · 10:06 AM EDT

Fortrea Holdings (FTRE) Free Cash Flow (2022 - 2026)

Fortrea Holdings' (FTRE) quarterly Free Cash Flow came in at $19.9 million in Q2 2026, up 39.16% on a YoY basis from $14.3 million in Q2 2025, and up 179.6% quarter-over-quarter from -$25.0 million in Q1 2026.

Analysis

Fortrea Holdings (FTRE) Free Cash Flow (2022 - 2026) Analysis & Trends

Fortrea Holdings (FTRE) has reported Free Cash Flow for 5 consecutive years, with $19.9 million the latest figure, recorded in Q2 2026.

  • For the quarter ending Q2 2026, Free Cash Flow rose 39.16% year-over-year to $19.9 million; the trailing twelve-month figure through Jun 2026 stood at $196.0 million (up 290.11% YoY), and the FY2025 full-year result was $88.3 million, down 62.79% from the prior year.
  • Free Cash Flow grew to $19.9 million in Q2 2026 per FTRE's latest filing, from -$25.0 million in the prior quarter.
  • Across five years, Free Cash Flow topped out at $262.5 million in Q2 2024 and bottomed at -$127.1 million in Q1 2025.
  • Historically, Free Cash Flow has averaged $32.4 million across 5 years, with a median of $11.6 million in 2023.
  • The widest YoY moves for Free Cash Flow: up 850.0% in 2025, down 264.18% in 2025.
  • Over 5 years, Free Cash Flow stood at $5.1 million in 2022, then surged by 76.47% to $9.0 million in 2023, then soared by 125.56% to $20.3 million in 2024, then soared by 499.01% to $121.6 million in 2025, then tumbled by 83.63% to $19.9 million in 2026.
  • According to Business Quant data, Free Cash Flow over the past three periods registered $19.9 million, -$25.0 million, and $121.6 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Free Cash Flow (Qtr)
1 Iqvia Holdings 42.29 Bn 40.21 Bn 1.44 Bn 360.00 Mn
2 Medpace Holdings 16.47 Bn 15.97 Bn 201.64 Mn 138.10 Mn
3 Charles River Laboratories International 13.17 Bn 12.98 Bn 452.07 Mn 148.62 Mn
4 Icon 12.39 Bn 11.46 Bn 479.29 Mn 323.69 Mn
5 Fortrea Holdings 1.57 Bn 1.40 Bn 139.20 Mn 19.90 Mn
6 Evotec SE 621.88 Mn 196.00 Mn - -
7 Ginkgo Bioworks Holdings 419.76 Mn 335.22 Mn 18.44 Mn -46.89 Mn
8 Champions Oncology 71.65 Mn 71.65 Mn 7.03 Mn -2.24 Mn
9 MindWalk Holdings 59.83 Mn 51.55 Mn 1.82 Mn -1.75 Mn
10 VivoSim Labs 1.45 Mn 1.45 Mn - -3.24 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 19.90 Mn
Mar 31, 2026 -25.00 Mn
Dec 31, 2025 121.60 Mn
Sep 30, 2025 79.50 Mn
Jun 30, 2025 14.30 Mn
Mar 31, 2025 -127.10 Mn
Dec 31, 2024 20.30 Mn
Sep 30, 2024 -10.60 Mn
Jun 30, 2024 262.50 Mn
Mar 31, 2024 -34.90 Mn
Dec 31, 2023 9.00 Mn
Sep 30, 2023 -3.20 Mn
Jun 30, 2023 140.50 Mn
Mar 31, 2023 -18.20 Mn
Dec 31, 2022 5.10 Mn
Sep 30, 2022 63.90 Mn